Kenya has signed a deal with US biotechnology company, Moderna Inc, to build a vaccine manufacturing facility in the country.The facility if expected to produce up to 500 million doses of vaccines annually.Kenyan President Uhuru Kenyatta ‘witnessed the signing of a memorandum of understanding on Monday between his country and Moderna in the capital Nairobi.’The new facility will help solve the problem of vaccine inequity experienced across Africa, which has not received its fair share of COVID-19 vaccines.“We are celebrating one of the greatest things that have possibly happened since the onse…